Progress on chemotherapy for triple negative breast cancer
10.3969/j.issn.1007-3969.2014.04.013
- VernacularTitle:三阴性乳腺癌化疗进展
- Author:
Chen NI
;
Ting LI
;
Zhenhua WU
;
Xichun HU
- Publication Type:Journal Article
- Keywords:
Triple negative breast cancer;
Molecular subtypes;
Neoadjuvant chemotherapy;
Adjuvant chemotherapy;
Palliative chemotherapy
- From:
China Oncology
2014;(4):316-320
- CountryChina
- Language:Chinese
-
Abstract:
Triple negative breast cancer (TNBC), as a special molecular subtype of breast cancer, is non-responsive to endocrine therapy or commercially available targeted therapy. It is characterized by early recurrence, rapid progression and poor prognosis. This systemic and comprehensive overview was focused on recent progress on molecular subtyping of triple negative breast cancer and its possible clinical value, chemotherapeutic agents and chemotherapy regimens, and combination of chemotherapy with potential molecular targeting agents.
